Consensus Avantor, Inc.

Stocks

AVTR

US05352A1007

Medical Equipment, Supplies & Distribution

Market Closed - NYSE Other stock markets 16:00:03 2026-07-24 EDT			5-day change	1st Jan Change
11.44 ^USD	+0.79%		+3.34%	-0.17%

07-14	Avantor Expands Collaboration With Population Council To Develop Three-Month Dapivirine Vaginal Ring For HIV Prevention	CI
07-14	Avantor's NuSil Brand Expands HIV Prevention Collaboration With Population Council	MT

Evolution of the Average Target: Avantor, Inc.

Evolution of the Target Price: Avantor, Inc.

Changes in Analyst Recommendations: Avantor, Inc.

5018dd78.Zyhs6jGGCqFqIqNrVQ1zIqWWX8A8bZRpXgN8y5XwHJo.ABgV23vtJ8MpQ-08LUE6S9X8MpdsBvIrNmwqkfqmUfdeWC-_W_Vu7hx1xA~1212d87a85feaa5dfcc4415864f96e81

Analysts' recommendations: Avantor, Inc.

07-13	BofA Securities Adjusts Avantor Price Target to $12 From $10	MT
05-15	Avantor's Turnaround Story Ongoing, Execution Risks Remain, RBC Says	MT
02-12	UBS Cuts Avantor Price Target to $10.50 From $13, Maintains Neutral Rating	MT
02-12	Deutsche Bank Cuts Price Target on Avantor to $9 From $12.50, Keeps Hold Rating	MT
12-17	Jefferies Downgrades Avantor to Underperform From Hold, Cuts Price Target to $9 From $12	MT
12-17	Analyst recommendations: Airbnb, Autozone, Constellation Brands, Fortinet, The Gap…
11-04	Raymond James Downgrades Avantor to Market Perform From Outperform	MT
11-04	Analysts recommendations: Apple, Comcast, Crocs, Eli Lilly, Palantir…
25-10-30	Avantor Shares Fall After JPMorgan, Barclays Downgrades	MT
25-10-30	JPMorgan Downgrades Avantor to Neutral From Overweight, Adjusts Price Target to $12 From $14	MT
25-10-30	Barclays Downgrades Avantor to Equalweight From Overweight, Adjusts Price Target to $12 From $15	MT
25-10-30	Analyst recommendations: Boeing, Alphabet, Caterpillar, Chipotle, Wayfair…
25-10-20	BofA Adjusts Price Target on Avantor to $16.50 From $14	MT
25-09-03	RBC Cuts Price Target on Avantor to $16 From $17, Keeps Outperform Rating	MT
25-08-04	Deutsche Bank Trims Avantor Price Target to $14 From $15, Maintains Hold Rating	MT
25-08-04	RBC Cuts Price Target on Avantor to $17 From $20, Keeps Outperform Rating	MT
25-08-01	Jefferies Downgrades Avantor to Hold From Buy, $12 Price Target	MT
25-08-01	Lab supplies firm Avantor's Q2 sales down 1%	RE
25-04-29	Goldman Sachs Downgrades Avantor to Neutral From Buy, Adjusts Price Target to $14 From $23	MT
25-04-28	Analyst recommendations: UnitedHealth Group, PepsiCo, Netflix, Philip Morris International, Comcast.
25-04-28	Stifel Downgrades Avantor to Hold From Buy, Adjusts Price Target to $14 From $26	MT
25-04-28	TD Cowen Downgrades Avantor to Hold From Buy, Adjusts Price Target to $15.50 From $20	MT
25-04-28	Morgan Stanley Downgrades Avantor to Equalweight From Overweight, Adjusts Price Target to $15 From $25	MT
25-04-28	Deutsche Bank Cuts Price Target on Avantor to $15 From $22, Keeps Hold Rating	MT
25-04-28	RBC Cuts Price Target on Avantor to $20 From $24, Keeps Outperform Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	AVANTOR, INC.					-8.76%
	ABBOTT LABORATORIES					+15.59%
	MEDTRONIC PLC					+17.58%
	CENCORA, INC.					+14.83%
	HOYA CORPORATION					+23.7%
	BECTON, DICKINSON AND COMPANY					+14.71%
	MEDLINE INC.					+31.41%
	DEXCOM, INC.					+19.86%
	WEST PHARMACEUTICAL SERVICES, INC.					+22.62%
	STERIS PLC					+17.99%
	Average					+16.95%
	Weighted average by Cap.					+17.75%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

11.44USD

Average target price

10.44USD

Spread / Average Target

-8.76%

High Price Target

19.00USD

Spread / Highest target

+66.08%

Low Price Target

7.000USD

Spread / Lowest Target

-38.81%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BofA Securities
UBS
Deutsche Bank Securities
Jefferies & Co.
Raymond James
JPMorgan Chase
Barclays
RBC Capital Markets
Goldman Sachs
Stifel Nicolaus
Morgan Stanley
TD Cowen
Baird
Evercore ISI
Citigroup
Bernstein
William Blair & Co.
Wells Fargo Securities
Credit Suisse
KeyBanc Capital Markets
Cowen
Cleveland Research
Piper Sandler
Truist Securities